Quark Pharmaceuticals Revenue and Competitors

Location

$61.4M

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Quark Pharmaceuticals's estimated annual revenue is currently $19.1M per year.(i)
  • 0
  • Quark Pharmaceuticals's total funding is $61.4M.

Employee Data

    00

Quark Pharmaceuticals's People

NameTitleEmail/Phone
1
CFOReveal Email/Phone
2
SVP Strategy/PlanningReveal Email/Phone
3
SVPReveal Email/Phone
4
eVP Regulatory AffairsReveal Email/Phone
5
VP, Medical InnovationReveal Email/Phone
6
svp Corporate Development and Investor RelationsReveal Email/Phone
7
SVP Quality AssuranceReveal Email/Phone
8
Chief Scientific OfficerReveal Email/Phone
9
Chief Medical OfficerReveal Email/Phone
10
Senior Director Clinical Research and Biostatistics, Statistics UnitReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$84.8M42224%N/AN/A
#2
$0.4M20%N/AN/A
#3
$32M1593%N/AN/A
#4
$35M1213%$62.5MN/A
#5
$30.2M15018%N/AN/A
#6
$135.3M6730%N/AN/A
#7
$110.3M549N/AN/AN/A
#8
$60.1M299-4%N/AN/A
#9
$554.8M17252%N/AN/A
#10
$10.5M524%N/AN/A
Add Company

What Is Quark Pharmaceuticals?

Quark Biotech, Inc. is a U.S. based biopharmaceutical company, focused on the development of drugs for unmet medical needs. Based on the proprietary targets identified using our enabling foundation technology, BiFAR, we are developing antibodies, siRNA based therapeutics and small molecules potentially applicable to several diseases. Our most advanced product, the small molecule BT16, is in clinical phase II for dyslipidemia.

keywords:N/A

$61.4M

Total Funding

N/A

Number of Employees

$19.1M

Revenue (est)

N/A

Employee Growth %

N/A

Valuation

N/A

Accelerator

Quark Pharmaceuticals News

2022-04-19 - Antisense & RNAi Therapeutics Market Size, Outlook And ...

... ICo Therapeutics, Quark Pharmaceuticals, Rexhan Pharmaceuticals ... Glaxo Smith Kline, Sanofi Aventis / Genzyme, Isis Pharmaceuticals/ Ionis...

2022-04-17 - Acute Kidney Injury Treatment Market Size, Scope And ...

Quark Pharmaceuticals Inc., Baxter International Inc., B. Braun Melsungen AG, Asahi Kasei Medical Co. Ltd., AM-Pharma B.V.,...

2022-04-17 - Acute Kidney Injury Therapeutics Market Size 2022-2029| Key ...

Quark Pharmaceuticals; Alloksys; Angio Biomedica Corporation; Stealth Bio Therapeutics; Silver Creek Pharmaceuticals; Am Pharma Holding; Ischemix; Biomerieux...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$4.5M0N/AN/A
#2
$65M0N/AN/A
#3
$1M0N/A$33.4M
#4
$11.3M0N/A$12M
#5
$0.1M10%N/A